Division of Gastroenterology, First Department of Medicine, Clinical Center, University of Pecs. Hungary.
CURE: Digestive Diseases Research Center, Building 115, Room 117, VA Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Los Angeles, CA 90073. United States.
Curr Pharm Des. 2017;23(27):4042-4047. doi: 10.2174/1381612823666170228142428.
The activation of Corticotrophin Releasing-Factor (CRF) receptors in the brain is well established to coordinate the endocrine, behavioral, autonomic and visceral responses to stress. In addition, CRF receptors are also expressed within the gut where they exert biological actions and play a role in modulating stress-related gastrointestinal function. In particular, peripheral injection of CRF and related peptides, urocortin 1, 2 or 3 inhibit Gastric Emptying (GE) and alters fasted and fed pattern of gastroduodenal motility in several experimental species. Urocortin 1 interacts synergistically with cholecystokin-8 to inhibit gastric emptying in lean mice which is no longer observed in diet-induced obese rats. In in vitro circular or longitudinal muscle preparation of rat antrum, CRF and urocortin 1 and 2 suppressed spontaneous contractile activity. CRF and urocortins interact with the CRF receptor 2 (CRF-R2) to inhibit gastric motor function monitored both in vivo and in vitro. The CRF-R2 mediated inhibition of antral and corpus contractility involves a direct action on gastric myenteric neurons where CRF-R2 is expressed and may also involve the activation of serotonin acting on 5-HT3 receptor. The involvement of peripheral CRF receptors in gastric motor alterations occurring under stress conditions are stressors specific with CRF-R2 mediating the early phase of gastric ileus induced by abdominal surgery and the delayed emptying elicited by acute restraint stress. However gastric stasis elicited by endotoxin is not mediated by CRF-R2 and CRF receptors are not involved in the basal regulation of fed or fasted pattern of gastric motility.
已知脑内促肾上腺皮质素释放因子 (CRF) 受体的激活可协调机体对压力的内分泌、行为、自主和内脏反应。此外,CRF 受体也在肠道内表达,在那里发挥生物学作用,并在调节与压力相关的胃肠道功能方面发挥作用。特别是,CRF 和相关肽、孤啡肽 1、2 或 3 的外周注射可抑制胃排空 (GE),并改变几种实验动物的空腹和进食时胃十二指肠动力模式。孤啡肽 1 与胆囊收缩素-8 协同作用,抑制瘦鼠的胃排空,而在饮食诱导肥胖大鼠中则不再观察到这种作用。在大鼠胃窦的环行或纵行肌标本中,CRF 和孤啡肽 1 和 2 抑制自发性收缩活性。CRF 和孤啡肽与 CRF 受体 2(CRF-R2)相互作用,抑制胃动力功能,无论是在体内还是在体外均有观察到。CRF-R2 介导的胃窦和胃体收缩抑制涉及胃肌间神经元的直接作用,在这些神经元中表达 CRF-R2,并且可能还涉及激活作用于 5-HT3 受体的 5-羟色胺。外周 CRF 受体在应激条件下发生的胃运动改变中起作用,这些改变是应激特异性的,CRF-R2 介导腹部手术引起的早期胃轻瘫和急性束缚应激引起的延迟排空。然而,内毒素引起的胃排空障碍不受 CRF-R2 介导,CRF 受体也不参与进食或禁食时胃动力模式的基础调节。